BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36303158)

  • 41. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
    Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.
    Rao X; Lu Y
    Mol Biotechnol; 2022 Nov; 64(11):1279-1287. PubMed ID: 35578071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo.
    Chen FT; Zhong FK
    Dis Markers; 2019; 2019():6383685. PubMed ID: 31772692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
    Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
    Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The centromere-associated protein CENPU promotes cell proliferation, migration, and invasiveness in lung adenocarcinoma.
    Lou Y; Lu J; Zhang Y; Gu P; Wang H; Qian F; Zhou W; Zhang W; Zhong H; Han B
    Cancer Lett; 2022 Apr; 532():215599. PubMed ID: 35176420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CircRNA CircZMYM4 inhibits the growth and metastasis of lung adenocarcinoma via the miR-587/ODAM pathway.
    Yuan DF; Wang HR; Wang ZF; Liang GH; Xing WQ; Qin JJ
    Biochem Biophys Res Commun; 2021 Nov; 580():100-106. PubMed ID: 34634673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
    Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
    Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
    [No Abstract]   [Full Text] [Related]  

  • 51. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
    Wang H; Sun Z; Zhao W; Geng B
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of LPGAT1 Enhances Lung Adenocarcinoma Proliferation.
    Gong H; Ma C; Li X; Zhang X; Zhang L; Chen P; Wang W; Hu Y; Huang T; Wu N; Wang X
    Front Biosci (Landmark Ed); 2023 May; 28(5):89. PubMed ID: 37258473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of HMGB2 associated with proliferation, invasion and prognosis in lung adenocarcinoma via weighted gene co-expression network analysis.
    Qiu X; Liu W; Zheng Y; Zeng K; Wang H; Sun H; Dai J
    BMC Pulm Med; 2022 Aug; 22(1):310. PubMed ID: 35962344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
    Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
    Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway.
    Wang C; Cheng B
    Bioengineered; 2022 Mar; 13(3):4869-4884. PubMed ID: 35196185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated Expression of
    Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
    DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation of CLEC3B facilitates epithelial-mesenchymal transition, migration and invasion of lung adenocarcinoma cells.
    Lu X; Shen J; Huang S; Wang H; Liu D
    Tissue Cell; 2022 Jun; 76():101802. PubMed ID: 35500520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
    Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
    BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
    Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.